ArticleMetabolism open2026
Clinical characteristics of fulminant type 1 diabetes mellitus following acute pancreatitis.
Article in Metabolism open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to gather clinical data on fulminant type 1 diabetes mellitus (FT1DM) following acute pancreatitis and investigate its clinical characteristics. Methods: A comprehensive search was conducted in PubMed, Embase, Web of Science, Wanfang Database, and China National Knowledge Infrastructure. This was complemented by manual screening strategies to identify FT1DM cases following acute pancreatitis that met the inclusion and exclusion criteria. Data pertaining to demographic, clinical, and laboratory results were extracted for descriptive analysis. Results: Fifteen cases met the eligibility criteria, with a male-to-female ratio of 7:8. The average age was 36.27 ± 13.46 years, and the mean BMI was 21.17 ± 3.08 kg/m Conclusion: A temporal association was observed between AP and subsequent FT1DM. Variations in the age of onset, positivity rate of islet-related antibodies, and diabetic family history among FT1DM patients could be attributed to different ethnic backgrounds and preceded factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.